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Abstract
This review critically evaluates the magnitude of performance enhancement that can be expected from various
autologous blood transfusion (ABT) procedures and the underlying physiological mechanisms. The review is based
on a systematic search, and it was reported that 4 of 28 studies can be considered of very high quality, i.e. placebo-
controlled, double-blind crossover studies. However, both high-quality studies and other studies have generally
reported performance-enhancing effects of ABT on exercise intensities ranging from ~70 to 100% of absolute peak
oxygen uptake (VO2peak) with durations of 5–45 min, and the effect was also seen in well-trained athletes. A linear
relationship exists between ABT volume and change in VO2peak. The likely correlation between ABT volume and
endurance performance was not evident in the few available studies, but reinfusion of as little as 135 mL packed
red blood cells has been shown to increase time trial performance. Red blood cell reinfusion increases endurance
performance by elevating arterial oxygen content (CaO2). The increased CaO2 is accompanied by reduced lactate
concentrations at submaximal intensities as well as increased VO2peak. Both effects improve endurance performance.
Apparently, the magnitude of change in haemoglobin concentration ([Hb]) explains the increase in VO2peak
associated with ABT because blood volume and maximal cardiac output have remained constant in the majority of
ABT studies. Thus, the arterial-venous O2 difference during exercise must be increased after reinfusion, which is
supported by experimental evidence. Additionally, it remains a possibility that ABT can enhance repeated sprint
performance, but studies on this topic are lacking. The only available study did not reveal a performance-enhancing
effect of reinfusion on 4 × 30 s sprinting. The reviewed studies are of importance for both the physiological
understanding of how ABT interacts with exercise capacity and in relation to anti-doping efforts. From an anti-
doping perspective, the literature review demonstrates the need for methods to detect even small ABT volumes.
Keywords: Phlebotomy, Transfusion, Arterial oxygen content, Maximal oxygen uptake, Maximal cardiac output,
Anti-doping
Key Points
 Autologous blood transfusion increases exercise
performance over a broad range of exercise
intensities and durations.
 The exact relationship between performance
increase and transfusion volume cannot be
established due to a lack of studies. Even low-
volume (135 mL) transfusions increase exercise
performance.
 Autologous blood transfusion increases maximal
oxygen uptake corresponding to the augmented
haemoglobin concentration, whereas maximal
cardiac output appears unaffected.
Background
One of the first studies of how autologous blood transfu-
sions (ABTs) affect exercise performance was completed
in 1960 and demonstrated that sustainable power output
at a heart rate of 170 bpm is impaired by ~ 8% after
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phlebotomy of ~ 600 mL and increases by ~ 4% after re-
infusion of the refrigerated whole blood [1]. Since then,
several studies have confirmed ABT to enhance exercise
performance in various modes and durations [1–16].
However, ABT is associated with health risks (i.e. bacter-
ial contamination, haemolysis, and allergic reactions)
[17] and is against the spirit of sport. Therefore, the use
of ABT is prohibited in competitive sports [18] and has
been since 1986.
The hitherto-performed ABT studies have never been
critically reviewed with a strong focus on research meth-
odology, although the performance-enhancing effect of
ABT appears well established and is in agreement with
solid physiological principles. Important factors for study
interpretation include number of participants, inclusion
of controlled trials, blinding, transfusion volume, storage
time, storage method, and exercise protocol. Considering
the strengths and weaknesses of the existing studies is
important not only for the physiological understanding
of how ABT interacts with exercise capacity but also for
anti-doping efforts, where knowledge of expected effects
helps target and prioritize in-competition and out-of-
competition testing. Thus, the present review aims to
evaluate the magnitude of performance enhancement
from various ABT procedures as well as to address the
existing knowledge of the associated physiological
mechanisms.
A systematic search for peer-reviewed publications
was performed at http://www.pubmed.com using the fol-
lowing query: (((autologous blood transfusion) OR (red
blood cell transfusion)) AND (performance OR exer-
cise)). In addition, the retrieved reference lists were ex-
amined for unidentified studies. The literature search
was terminated in January 2019. The exclusion criteria
were studies published as abstracts only, studies on pa-
tients, and studies investigating the combination of ABT
and high altitude acclimatization because altitude
acclimatization may enhance performance [19]. In total,
28 research articles were included (Table 1).
Effect of ABT on Human Exercise Performance
Intensity, Duration, and Training Status
The following section considers the importance of exer-
cise intensity, exercise duration, and participants’ train-
ing status for the effect of ABT on human performance.
In one of the first studies to address ABT’s effect on
human exercise performance, time to exhaustion (TTE)
lasting ~ 5min increased 23% following reinfusion with
800 mL refrigerated packed red blood cells (RBCs)
collected 4 weeks earlier [13]. The TTE was determined
from treadmill running at a constant grade with a speed
requiring maximal oxygen uptake (VO2peak). Likewise,
TTE lasting ~ 6min increased by ~ 25% compared to
before collection when four participants received cold-
stored packed RBCs from the sequential donation of
1200 mL of blood obtained ~ 30 days earlier [13].
However, the small sample size, the lack of a control
group, and the non-blinded design preclude firm conclu-
sions. When applying a double-blind, placebo-controlled
crossover design and 7–11 weeks cryopreservation, per-
formance was enhanced by ~ 30% in a TTE lasting ~ 10
min [10] and by 3% in 5 mile and 10 km time trials (TT)
[9, 14] in well-trained males receiving a reinfusion of
RBCs reconstituted to normal haematocrit (Hct) from a
~ 900mL donation. Generally, the high-quality ABT
studies report enhanced performance by ~ 3–5% com-
pared with pre-reinfusion performance in time trials
lasting ~ 30–45 min [7, 9, 14] and that TTE is prolonged
by ~ 30% in a test lasting ~ 10 min [10]. It is of note that
all the best controlled studies investigated well-trained
male athletes (Table 1). Moreover, the performance
enhancement was evident when evaluated a few days be-
fore and after reinfusion [1, 3–11, 13–16]. Importantly,
both reinfusion of cryopreserved RBCs and reinfusion of
cold-stored RBCs improve exercise performance irre-
spective of total haemoglobin mass recovery, which may
be incomplete, especially in the context of cold storage,
where ≤ 4 weeks elapse between donation and reinfusion
[1, 6–8, 13, 30]. In support of the performance-
enhancing effect of ABT, both high-quality and low-
quality studies generally report that blood reinfusion im-
proves exercise performance in tasks lasting from ~ 5 to
~ 45 min, which corresponds to exercise intensities of
approximately 70 to ~ 100% of VO2peak. Furthermore,
performance enhancement has been observed in both
untrained and well-trained men (Table 1). Notably, the
only study enrolling only women [5] also reported im-
proved performance, but a lack of studies addressing a
possible sex-specific effect is apparent. In relative terms,
the effect of ABT in open-ended performance tests, i.e.
TTE tests with a relatively short duration, appears super-
ior, with an improvement range of 16–40%, to close-
ended tests, i.e. TT tests of longer duration, with an
improvement range of 3–5% (Table 1).
ABT Volume and Physiological Effects
In the present section, it is considered whether a dose-
dependent effect of ABT exists on maximal aerobic
power and exercise performance.
Standard-Volume, High-Volume, and Low-Volume ABT
Reinfusion of cold-stored RBCs from 450–500 mL
donations, herein termed ‘standard-volume ABT’,
enhances 3 km treadmill time-trial performance by ~ 5%
in moderately trained men [6] and TTE at maximal
aerobic workload by ~ 40% in untrained men [16].
However, in some studies, reinfusion of 450 mL whole
blood or 200mL packed RBCs reconstituted with
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physiological saline to a normal Hct did not result in de-
tectable performance gains in moderately trained to
well-trained males, neither following cryopreservation
[24, 28] nor after cold storage [21, 23]. Five of eight
studies investigating reinfusion of a ‘standard-volume’
corresponding to ~ 500 mL reported improved per-
formance, and the three negative findings must be
interpreted cautiously (Table 1). There are several
possible explanations why some studies have not ob-
served an effect of a single standard-volume autolo-
gous reinfusion on VO2peak or performance. First, the
precision and random variation in the physiological
measurements may mask performance-relevant in-
creases. This explanation seems likely since inclusion
of, for example, four subjects yields a detection limit
for changes in absolute VO2peak of ~ 6% when assum-
ing a measurement error of 3% [33]. Moreover, Bell
and co-workers [23] did not observe improved TTE,
which appears to be likely related to variation in the
small group of 5 subjects. Indeed, a numerical in-
crease of > 20% in TTE was apparent in the ABT
group, but unfortunately, no data on variation was re-
ported for this outcome variable. Second, RBC storage
lesions and degradation after reinfusion can be of
importance since only ~ 70% (cold-stored) or ~ 50%
(cryopreserved) of the haemoglobin (Hb) is preserved
after storage [34]. Furthermore, ~ 25% of the infused
RBCs can be degraded within 24 h [35], and a detect-
able effect of ABT on exercise performance immedi-
ately after reinfusion may disappear within a few
days. In addition to variations in measures of physio-
logical function and RBC storage lesions, low statis-
tical power for determining subtle performance
fluctuations and the selection of time points for per-
formance evaluation are important. For instance,
comparison of performance before blood donation
and after reinfusion separated by 21 days [21] intro-
duces variation over time as well as a risk of insuffi-
cient haemoglobin mass recovery [6, 36]. Indeed,
when performance was evaluated prior to phlebotomy
and after the reinfusion 21 days later, 10 of 15 partici-
pants performed 4–5% worse [21]. However, this find-
ing appears more likely to be related to an
insufficient total haemoglobin (tHb) recovery period
and natural fluctuations in exercise capacity than lack
of effect of ABT on performance. Clearly, variation in
measurements, physiological ability, RBC storage le-
sions, and RBC degradation as well as study design
impact the outcome of studies evaluating the effect of
standard-volume ABTs on exercise performance.
The same study design factors as outlined above affect
studies of ABT with larger volumes, but the expected
higher ‘signal-to-noise’ ratio reduces the risk of not iden-
tifying meaningful effects. However, when interpreting
studies of ABT volumes of ~ 900 mL or more, which is
the case for 17 of the studies listed in Table 1, it must be
considered whether the associated increase in blood vis-
cosity lowers maximal cardiac output (Qmax) more than
increased arterial oxygen content (CaO2) can compen-
sate for [28] or if it even reduces tissue perfusion. Com-
promised Qmax appears of little relevance because an
autosomal dominant erythrocytosis carrier (i.e. increased
sensitivity to EPO) with a haematocrit of more than 60%
is also an endurance sport Olympic gold medallist [37].
With regard to tissue oxygen delivery, O2 consumption
and contractile power of blood-perfused canine gastro-
cnemius muscles are compromised only when haemato-
crit is higher than 60%, despite reduced absolute blood
flow [38]. In support of the above observations, exercise
performance in rodents is optimal at a haematocrit of
approximately 60% [39]. Thus, even markedly elevated
blood viscosity after high-volume ABT does not coun-
teract the performance-enhancing effect. This notion
is supported by the high-quality studies of ABT
volumes ~ 900 mL reporting improved exercise per-
formance in humans [9, 10, 14].
The possible performance-enhancing effects of ABTs
of less than 450 mL, termed ‘low-volume ABT’ in the
present review, have not yet been fully scientifically ad-
dressed (Table 1), even though dishonest athletes are
suspected to reinfuse low (≤ 150–200 mL) volumes [40].
To our knowledge, we recently completed the first study
on the effect of a low-volume ABT using a randomized,
double-blind, placebo-controlled crossover design. We
demonstrated that reinfusion with ~ 135 mL of cold-
stored RBCs, corresponding to ~ 225 mL of whole blood,
is sufficient to increase mean power by ~ 5% and reduce
elapsed time by ~ 4% in a 650 kcal cycling TT [7].
Concomitantly, haemoglobin concentration ([Hb]), Hct,
and RBC count increased by 3% compared to their levels
3 days before reinfusion. Hence, even low ABT volumes
improve exercise performance.
Is There an ABT Dose-Response Relationship?
Only a few studies have directly addressed whether ABT
volume is decisive for the magnitude of effect on abso-
lute VO2peak and/or exercise performance. One of the
earliest studies to investigate the dose-dependency of
ABT on VO2peak applied stepwise reinfusions separated
by 2–7 days [28]. Each reinfusion consisted of freeze-
preserved RBCs, reconstituted with physiological sa-
line to a normal Hct, from 450 mL whole blood har-
vested 9–11 weeks earlier [28]. The direct effect on
endurance performance was not evaluated, but the
primary outcome, VO2peak, surprisingly remained
unchanged following the first reinfusion in the four
well-trained endurance runners. VO2peak did, however, in-
crease non-significantly (p > 0.05) by ~ 200mL O2/min
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(4%) in all four subjects after the second reinfusion, and
an additional significant increase to ~ 340mL O2/min
(7%) above control was observed after the third reinfusion
[28]. Thus, an undetected dose-dependent response may
have been apparent. This interpretation is supported by
the gradual increase in VO2peak observed with four succes-
sive reinfusions of 450mL [31]. Thus, the impact of ABT
on VO2peak apparently follows a dose-response relation-
ship, as could be expected, although a well-designed study
to address this question is lacking.
Does Storage Technique Impact ABT’s Effect on Exercise
Performance?
Two main techniques are used for RBC storage: refriger-
ation (cold storage) or freezing (cryopreservation). In the
clinical setting, cold-stored RBCs must be reinfused after
35–42 days, depending on the storage solution, due to
increasing storage lesions, whereas cryopreservation al-
lows for storage for up to 30 years [41]. Cold-stored
blood appears to be the least probable strategy used by
dopers because 20–59 days is required for full tHb
restoration after an ~ 550mL phlebotomy [42] and the
effect on [Hb], and thus performance, may be counter-
acted by suppressed haemoglobin mass at the time of re-
infusion. On the other hand, pre-reinfusion handling of
cryopreserved blood is associated with a 20% larger loss
of the initially removed Hb compared with that of refrig-
erated blood due to the necessary freeze-thaw-wash
process following cryopreservation [34]. Moreover, cryo-
preservation is more expensive and technically challen-
ging than cold storage. No studies have directly
compared the impact of storage technique on perform-
ance. However, it is important to note that the evalu-
ation of ABT’s effect on exercise capacity requires that
the performance evaluation be completed a few days be-
fore and after reinfusion, independent of storage tech-
nique. Evidently, both storage techniques are able to
enhance aerobic performance (Table 1), although the
shortcomings of the existing protocols need to be
acknowledged.
Study Design Considerations
Several factors influence the interpretation of ABT and
exercise performance studies. These factors include
storage technique, number of participants, inclusion of
control trials, blinding procedure, transfusion volume,
storage time, exercise protocol, and statistical analyses.
From a human performance and anti-doping perspec-
tive, the lack of a statistically significant difference
following a treatment is of limited value if just one
participant gains a competitive advantage. The margin of
difference between competitors is small, and a < 1%
effect is of relevance. However, such small changes are
difficult to detect in a scientific study. A useful approach
in this context could be the evaluation of clinical signifi-
cance or relevance by reporting effect sizes and minimal
clinically important differences [43]. However, the sensi-
tivity issue appears to be of less importance in ABT
studies, as a performance-enhancing effect of several
percent is present, even when low-volume transfusions
are applied [7]. To date, six studies with endurance per-
formance measurements have applied a double-blind,
placebo-controlled design with a total of 6–20 partici-
pants [7, 9, 10, 14, 21, 24]. All except two [21, 24] of
these studies reported improved performance after the
reinfusion of autologous blood, which may be ascribed
to a sample size of 5 [21] or 8 [24] in each group or
variation in the measurements.
Physiological Mechanisms Responsible for the
Performance-Enhancing Effect of ABT
Theoretically, endurance performance is related to
VO2peak relative to body weight and the % of VO2peak
that can be sustained during prolonged intense endur-
ance exercise (i.e. 30–40min for a 10-km run). However,
how does ABT alter VO2peak and the ability to sustain a
high percentage of VO2peak? In the following sections,
the physiological mechanisms that may explain the
performance-enhancing effect of ABT are considered.
ABT Increases Maximal Muscular Oxygen Delivery
Maximal O2 delivery to the contracting limb muscles
can be augmented via increased limb blood flow, in-
creased CaO2, or both. An increase in maximal limb
blood flow requires increased Qmax or altered blood flow
distribution. In the ‘Is Maximal Cardiac Output In-
creased by ABT?’ and ‘Is Maximal Limb O2 Delivery and
Extraction Increased by ABT?’ sections, ABT’s potential
effect on Qmax, limb blood flow, and CaO2 is addressed.
Is Maximal Cardiac Output Increased by ABT?
When maximal exercise with a large muscle mass is per-
formed in normoxia, Qmax determines the upper limit
for O2 delivery to the active muscle groups and thereby
becomes the limiting factor for VO2peak in endurance-
trained, untrained, and generally healthy individuals [44].
Hence, increasing Qmax will increase an individual’s
maximal oxygen uptake and thereby also maximal en-
durance performance by allowing the individual to exer-
cise at a higher absolute workload, while metabolism
remains primarily aerobic [45]. In cross-sectional stud-
ies, total blood volume and tHb are tightly associated
with VO2peak, whereas [Hb] is not [46]. In agreement
with this idea, Qmax is closely related to VO2peak [47],
and thus, it may be hypothesized that an increased blood
volume can increase Qmax and thereby performance.
Indeed, a training-induced expansion of total blood
volume appears to be the primary cause of increased
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VO2peak via increased Qmax [48]. Thus, it is tempting to
suggest that the ABT-induced increase in tHb increases
VO2peak by increasing Qmax. However, it is important to
note that the close association between absolute VO2peak
and tHb when determined in a mixed group of humans
is caused primarily by differences in size, including ven-
tricular mass and total blood volume, which defines
Qmax [47], whereas no close association is evident in a
homogenous group of athletes [49]. With respect to the
effect of blood reinfusion on VO2peak, it is important
that total blood volume alterations appear to depend on
the time of investigation after reinfusion. Total blood
volume appears unaffected ≥ 24 h post-reinfusion of 800
to 2250 mL of refrigerated whole blood [22] as well as
refrigerated [50] or freeze-preserved [31, 32, 50] RBCs
reconstituted with physiological saline to a normal Hct.
In contrast, 1 h after reinfusion of packed RBCs from
900mL of whole blood, a 5% increase in total blood vol-
ume occurs together with increases in Hct (2%), [Hb]
(4%), VO2peak (7%), and cycling performance lasting 3–6
min (24%) [11]. As such, total blood volume may be un-
affected by ABT when determined more than 24 h after
reinfusion due to a rapid compensatory reduction in
plasma volume. However, the small number of studies
on ABT and total blood volume and the variances and
challenges associated with blood volume determination
preclude a firm conclusion.
Reinfusion of autologous blood acutely increases cen-
tral venous pressure [20], which usually increases Qmax
due to an enlarged end-diastolic volume and thereby
causes a higher stroke volume and Qmax, according to
the Frank-Starling mechanism [51]. However, it is likely
that the increased central venous pressure after blood
reinfusion is transient (< 24 h) and related to the acute
volume expansion, but this remains to be investigated.
The most direct approach to determine the effect of
ABT on Qmax is to measure Qmax. A few studies have
directly evaluated Qmax after blood reinfusion. In 7
males who received RBCs obtained from 900mL dona-
tions 2–3months earlier, no difference existed approxi-
mately 24 h after reinfusion in the invasively determined
Qmax of ~ 22 L/min, despite a clear ~ 3% increase in
VO2peak [15]. In 9 women, reinfusion of RBCs from two
450mL phlebotomies, conducted 9 and 17 weeks prior,
did not alter the Qmax of ~ 17 L/min, as indirectly deter-
mined 48 h later by CO2 rebreathing [5]. Moreover, in
four male endurance runners, the reinfusion of RBCs
from 900–1350 mL blood 3–4 weeks after phlebotomy
increased VO2peak but only non-significantly increased
dye dilution-determined Qmax from ~ 28 to ~ 33 L/min
approximately 2 days later [28]. Thus, Qmax appears
unaffected even by reinfusion of rather large volumes
and cannot explain the increase in VO2peak and perform-
ance after ABT. In this context, it must be noted that
determination of Qmax is technically difficult and associ-
ated with variance; therefore, a moderate undetected
effect of ABT on Qmax may exist.
Is Maximal Limb O2 Delivery and Extraction Increased by ABT?
Limb blood flow can be as high as 2000–3000mL/min
per kg of muscle [52], and the muscular oxygen uptake
capacity is ~ 600 mL/kg/min in healthy subjects, which
is much higher than the amount of O2 supplied during
whole-body exercise [53]. Hence, it is evident that limb
blood flow is limited by Qmax during intense whole-body
exercise. Thus, if maximal limb blood flow during in-
tense whole-body exercise is increased by reinfusion, this
would increase maximal aerobic energy production and
thereby performance. However, maximal limb blood flow
appears unlikely to increase since Qmax appears un-
affected by reinfusion, as highlighted in the ‘Is Maximal
Cardiac Output Increased by ABT?’ section. In this con-
text, it must be noted that, for example, brain blood flow
is primarily dependent on CaO2 [54], and therefore, the
ABT-induced increase in arterial oxygen content may re-
duce blood flow to other tissues and organs. As a conse-
quence, it remains a possibility that more blood is
redistributed to the exercising muscles and that maximal
limb blood flow is marginally increased by RBC reinfu-
sion despite unaltered Qmax. However, this hypothesis
remains to be investigated.
Reinfusion of autologous blood is usually [7, 10, 13,
14, 28, 31, 32], but not always [3], accompanied by ele-
vated Hct and/or [Hb] compared to the pre-reinfusion
levels. Accordingly, reinfusion increases the O2 carrying
capacity per litre of blood, and this has been highlighted
in previous reviews as the main physiological mechan-
ism causing enhanced performance following ABT [55].
Indeed, stepwise reinfusions of four blood bags, in eight
untrained to moderately trained men, resulted in
VO2peak increases of approximately 40 mL O2/min (1%),
130 mL O2/min (3%), 230mL O2/min (5%), and 320 mL
O2/min (7%) and increases in [Hb] of approximately 4%,
7%, 12%, and 13% from the first to the last reinfusion,
respectively [31], as mentioned in the ‘Is There an ABT
Dose-Response Relationship’ section. This result resem-
bles the findings of Spriet and co-workers [28] and cor-
responds to an approximately 0.47% increase in VO2peak
per 1% increase in [Hb] (R2 = 0.97) [31]. For the ABT-
induced increase in [Hb] to augment VO2peak without
affecting Qmax, the arterial-venous O2 difference (a-v O2
difference) across the exercising muscle groups must be
increased. The ABT-induced increase in CaO2 and
concurrent unchanged [15, 25] or reduced [22] mixed
venous O2 content (CvO2) strongly suggest an increased
extraction [15] after reinfusion, but the small sample
sizes (n = 4–7) preclude a firm conclusion.
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ABT, Anaerobic Energy Production, and Metabolic Acidosis
Blood Lactate Response to Exercise
Increased maximal capacity for oxygen delivery likely re-
duces the anaerobic energy contribution at intensities
above ~ 70% of VO2peak, as illustrated by reduced plasma
lactate concentrations ([La]) after ABT measured at the
same absolute workload [5]. The reinfusion of RBCs
packed saline obtained from phlebotomy of 900 mL and
1350 mL whole blood causes a marked reduction in
blood lactate values following exercise at 91% of VO2peak
(from ~ 6mM before reinfusion to ~ 2mM after) and
after maximal treadmill running at 100% of control
VO2peak (from ~ 12 mM before to ~ 5 mM after), con-
comitant with less disturbed arterial acid-base status 5
min after exercise [28]. Furthermore, blood reinfusion re-
duces the lactate concentration by approximately 50% in
runners when determined 4min after submaximal (~ 70%
VO2peak) treadmill running [10]. In five trained subjects,
venesection increased the lactate response to exercise at
~ 70% of VO2peak from 6.0 to 7.6 mM, while reinfusion re-
duced lactate to 4.6 mM [22]. This reduction in plasma-
borne markers of anaerobic energy contribution during
submaximal exercise may increase the %VO2peak defining
the lactate threshold, which is an important determinant
of endurance performance [56, 57]. Since most endurance
competitions are not performed at intensities correspond-
ing to 100% of VO2peak, this may be the most important
performance-enhancing effect of ABT. However, it should
also be acknowledged that some parts, e.g. the final part of
a 5000-m or 10,000-m race, a cycling stage with mountain
climbs or the like, are likely to elicit VO2peak.
Blood pH Response to Exercise
During intense exercise, anaerobic energy production re-
sults in increased plasma hydrogen concentration ([H+])
[58]. Metabolic acidosis is immediately counteracted by
hyperventilation, bicarbonate buffering, and non-
bicarbonate buffering. The relationship between changes in
plasma lactate concentration and pH is indicated by the in
vivo buffer capacity: Δ[La-]/ΔpH [59]. RBCs are primary
extracellular buffers, and therefore, the total blood buffer
capacity depends on the total RBC volume and the expres-
sion of RBC membrane-bound transport systems, such as
the AE1 isoform of the anion-exchange transporter [60,
61] and the MCT1 isoform of the monocarboxylate trans-
porter (La−/H+ co-transporter) [61], as well as the enzyme
cytoplasmic carbonic anhydrase, which catalyses the re-
versible hydration of carbon dioxide (CO2); CO2 + H2O
(water)⇋ H2CO3 (carbonic acid)⇋ HCO3
− (bicarbonate)
+ H+ [60, 61]. Hence, the RBCs added through ABT have
the potential to theoretically improve systemic pH regula-
tion. However, the possible effect is small since a low-
volume ABT expands the total RBC volume by only a few
percent. Nevertheless, the relevance for performance in
elite sports with small margins may exist, but this remains
to be investigated.
Possible Influence of ABT on Anaerobic
Performance and Repeated Sprints?
The reinfusion of autologous blood increases the maximal
muscular oxygen uptake, which is the product of limb
blood flow and arterial-venous O2 difference. Blood rein-
fusions might also increase performance in short, anaer-
obic, intermittent exercises. Since the aerobic energy
provision increases when sprints are repeated [62, 63] and
the aerobic capacity is important for recovery between
sprints [64], it appears likely that repeated sprint ability is
improved by blood reinfusion. [La−] in blood and muscle
increases progressively during a 4 × 30 s all-out air-braked
cycle test in moderately trained males [65]. Additionally,
muscle La− accumulates non-linearly during a 2 × 30 s all-
out cycle test at a work load corresponding to 0.075 × kg
of body weight [66] and during 3 × 30 s all-out isokinetic
cycling at 100 rpm in healthy, recreationally active subjects
[58]. The highest impact of blood reinfusion on repeated
sprint ability is thus likely to occur in the later sprints. In
support of this notion, the level of aerobic ATP provision
during sprints has been found to increase progressively as
work duration increases [67, 68] and as sprints are re-
peated [62, 63]. Additionally, the potentially improved
blood buffer capacity during polycythaemia might contrib-
ute to the extracellular pH defence against lactic acidosis,
as outlined in the ‘ABT, Anaerobic Energy Production,
and Metabolic Acidosis’ section [59, 61]. Furthermore, the
nature of the recovery between sprints is likely of import-
ance for repeated sprint ability. For example, active recov-
ery is advantageous for the mean power output of sprints
when repeated Wingate anaerobic tests are performed
[62]. The O2 availability for mitochondria is known to be
decisive for creatine phosphate recovery [69], and an
ABT-induced increase in CaO2 thus appears likely to im-
prove recovery between sprints. Supporting this theory,
the 11% increase in [Hb], following recombinant human
EPO administration, reduces the accumulation of blood
La− and plasma hypoxanthine after fifteen 6-s high-
intensity uphill running sprints with 24 s of passive rest
[70]. Interestingly, in the only study to investigate the ef-
fect of ABT on repeated cycling sprint ability, we observed
no change in performance after reinfusion, despite an ~
9% increase in tHb and [Hb] [7]. The combined effect of
the reinfusion of ~ 135 and ~ 235 mL cold-stored
RBCs, corresponding to approximately 675 mL whole
blood, did not alter 4 × 30 s all-out cycling perform-
ance, either when determined as the mean power of
all sprints or when evaluated as the mean power in
each sprint. The two reinfusions were performed
within ~ 24 h, and the performance was evaluated a
few days before the first reinfusion and after the last
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reinfusion, separated by 8 days, as opposed to before
the phlebotomy and after the reinfusion. This allowed
for the evaluation of ABT-induced changes, although
the haematological parameters had not returned to
the pre-phlebotomy level at the time of reinfusion.
The results suggest that reinfusion with ~ 370 mL of
packed RBCs does not affect repeated sprint ability as
measured by 4 × 30 s of all-out cycling interspersed
with 4 min of rest. However, the effect of ABT in
other repeated sprint modalities and the effect of
larger ABT volumes are unknown.
Overall, the literature is scarce regarding the effects of
ABT on repeated sprint performance. Nevertheless, the
aforementioned potential effects of ABT in enhancing
O2 delivery and blood buffer capacity might be reflected
in improvement in fatigue resistance during repeated
sprints and thereby enhanced repeated sprint perform-
ance in some repeated sprint modalities.
Conclusion
The literature review revealed that ABT enhances per-
formance across a span of exercise intensities from ~ 70
to 100% of VO2peak and durations of 5–45min, and
these results were also observed in well-trained athletes.
The impact of ABT on VO2peak apparently exhibits a
dose-response relationship, but well-designed studies of
likely associated gradual performance effects are lacking.
However, reinfusion with as little as 135 mL packed
RBCs increases time-trial performance. Red blood cell
reinfusion increases endurance performance by elevating
CaO2. The increased CaO2 is accompanied by increased
VO2peak as well as reduced lactate concentrations, i.e. re-
duced anaerobic energy contribution at submaximal in-
tensities. Both effects improve endurance performance,
the latter because most endurance competitions are not
performed at intensities corresponding to 100% of
VO2peak. Apparently, the magnitude of change in haemo-
globin concentration explains the increase in VO2peak as-
sociated with ABT because blood volume and maximal
cardiac output remain constant in the majority of ABT
studies. Thus, the arterial-venous O2 difference during
exercise must be increased after reinfusion, which is sup-
ported by experimental evidence. Additionally, it remains
a possibility that ABT can enhance repeated sprint per-
formance, but studies are lacking. The only available study
did not observe a performance-enhancing effect of reinfu-
sion on 4 × 30 s sprinting.
The findings are of importance for both the physio-
logical understanding of how ABT interacts with exer-
cise capacity and in relation to anti-doping efforts. From
an anti-doping perspective, the literature review demon-
strates the need for analytical methods able to detect
even minor blood manipulations.
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